Norges Bank
CLVS

Norges Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

Norges Bank’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-313,167
Closed -$3.27M – 2091
2019
Q4 		$3.27M Buy
313,167
+18,324
+6% +$133K ﹤0.01% 1944
2019
Q3 		$1.16M Sell
294,843
-170,132
-37% -$1.38M ﹤0.01% 2026
2019
Q2 		$6.92M Hold
464,975
– – ﹤0.01% 1892
2019
Q1 		$11.5M Hold
464,975
– – ﹤0.01% 1755
2018
Q4 		$8.35M Hold
464,975
– – ﹤0.01% 1802
2018
Q3 		$13.7M Hold
464,975
– – ﹤0.01% 1713
2018
Q2 		$21.1M Hold
464,975
– – 0.01% 1481
2018
Q1 		$24.6M Sell
464,975
-30,681
-6% -$1.79M 0.01% 1295
2017
Q4 		$33.7M Buy
495,656
+27,677
+6% +$1.94M 0.01% 1083
2017
Q3 		$38.6M Sell
467,979
-37,503
-7% -$2.97M 0.01% 959
2017
Q2 		$47.3M Buy
505,482
+63,628
+14% +$3.89M 0.02% 773
2017
Q1 		$28.1M Buy
441,854
+145,709
+49% +$8.86M 0.01% 1144
2016
Q4 		$13.2M Buy
296,145
+24,600
+9% +$866K 0.01% 1568
2016
Q3 		$9.35M Buy
271,545
+48,972
+22% +$1.05M ﹤0.01% 1687
2016
Q2 		$3.05M Hold
222,573
– – ﹤0.01% 1955
2016
Q1 		$4.27M Hold
222,573
– – ﹤0.01% 1886
2015
Q4 		$7.79M Hold
222,573
– – ﹤0.01% 1723
2015
Q3 		$20.5M Buy
222,573
+50,910
+30% +$4.41M 0.01% 1117
2015
Q2 		$15.1M Hold
171,663
– – 0.01% 1376
2015
Q1 		$12.7M Buy
171,663
+14,802
+9% +$1.05M 0.01% 1506
2014
Q4 		$8.78M Buy
156,861
+49,110
+46% +$2.58M ﹤0.01% 1698
2014
Q3 		$4.89M Sell
107,751
-246,223
-70% -$10.3M ﹤0.01% 1929
2014
Q2 		$14.7M Buy
+353,974
New +$18.2M ﹤0.01% 1772

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Norges Bank's CLVS Position: Q1 2020 in Review

Norges Bank sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 313,167 shares — an estimated $3.27M sold.

Norges Bank first reported a position in CLVS in Q2 2014 and held it in 23 quarters. The position peaked at $47.3M in Q2 2017. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

  • Norges Bank reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
  • Norges Bank sold 313,167 Clovis Oncology, Inc. shares in Q1 2020, an estimated $3.27M.
  • Norges Bank first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 23 quarters.
  • Norges Bank's Clovis Oncology, Inc. position peaked at $47.3M in Q2 2017.
  • 154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.